Profiel
argenx SE is een in Nederland gevestigd biotechnologiebedrijf. Het bedrijf werd opgericht in 2008. argenx SE richt zich op het ontdekken, ontwikkelen en commercialiseren van antilichaamtherapieën voor de behandeling van ernstige auto-immuunziekten en kanker.
Adres
| Adres |
Laarderhoogtweg 25 |
| Postcode |
1101 EB |
| Stad |
Amsterdam |
| Land |
Netherlands |
| Telefoon |
+31107038441 |
| Fax |
|
| Email |
info@argenx.com |
| Website |
https://www.argenx.com/investors |
Bestuur
| Functie |
Titel |
Voornaam |
Achternaam |
| CDO |
|
Arjen Lemmen |
|
| CEO |
|
Tim Van Hauwermeiren |
|
| CFO |
|
Karl Gubitz |
|
| Chairman (Board of Directors) |
|
Peter Verhaeghe |
|
| CMO |
|
Luc Truyen |
|
| COO |
|
Karen Massey |
|
| CSO |
|
Peter Ulrichts |
|
| Member of Board of Directors |
|
Ana Cespedes |
|
| Member of Board of Directors |
|
Pamela M. Klein |
|
| Member of Board of Directors |
|
A.A. Rosenberg |
|
| Member of Board of Directors |
|
Camilla Sylvest |
|
| Member of Board of Directors |
|
Steve Krognes |
|
| Member of Board of Directors |
|
James M. Daly |
|
| Member of Board of Directors |
|
Tim Van Hauwermeiren |
|
| Member of Board of Directors |
|
Don deBethizy |
|
| Member of the Management Board |
|
Andria Wilk |
|
| Member of the Management Board |
|
Beth DelGiacco |
|
| Member of the Management Board |
|
Malini Moorthy |
|
| Member of the Management Board |
|
Filip Borgions |
|
| Member of the Management Board |
|
Marc Schorpion |
|